FDA Dietary Supplement Division Soon May Need Office Accommodations
This article was originally published in The Tan Sheet
Executive Summary
Without an objection from Congress, FDA’s Division of Dietary Supplement Programs becomes a CFSAN office on Dec. 21. Objections or questions from one or more members are possible, but HHS likely would not make the notification without high confidence Congress would not object.
You may also be interested in...
US FDA’s Human Foods Program Reorganization Plan Isn’t Palatable To Supplement Industry
Reorganization of CFSAN and related ORA operations into “unified Human Foods Program” would move ODSP into Office of Food Chemical Safety, Dietary Supplements and Innovation. Stakeholders plan to influence agency against making the change, or sway lawmakers to object, similar to what they did pushing for ODSP’s establishment less than 10 years ago.
Welch Leads US FDA’s Dietary Supplement Office
Center for Food Safety and Applied Nutrition says Cara Welch selected to fill Office of Dietary Supplement Programs director post. She’ll move up from ODSP deputy director on 14 March.
US FDA's Dietary Supplement Programs Deserve A Raise, Trade Groups Tell Senate Appropriators
Compliant industry drove US market growth to $55bn in 2020, and faster growth and higher sales are ahead if FDA’s Office of Dietary Supplement Programs has sufficient funding to eliminate non-compliant businesses.